Skip to main content

CORRECTION article

Front. Neurol.
Sec. Dementia and Neurodegenerative Diseases
Volume 15 - 2024 | doi: 10.3389/fneur.2024.1509655

Corrigendum: The use of plasma exchange with albumin replacement in the management of Alzheimer's disease: a scoping review Cantero-Fortiz, et al

Provisionally accepted
Yahveth Cantero-Fortiz Yahveth Cantero-Fortiz 1,2*Merce Boada Rovira Merce Boada Rovira 1,2
  • 1 Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain
  • 2 Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Asturias, Spain

This article is a correction to:

  1. The use of plasma exchange with albumin replacement in the management of Alzheimer’s disease: a scoping review

    1. Read original article

The final, formatted version of the article will be published soon.

    Corrigendum on: Cantero-Fortiz Y, Boada M. The use of plasma exchange with albumin replacement in the management of Alzheimer's disease: a scoping review. Front Neurol. 2024;15. doi: 10.3389/fneur.2024.1443132. In the published article, there was an error. We made a typo regarding the significance of the results using 'p<0.05' instead of 'p>0.05'. Despite the Clinical relevance, there was no statistical significance. Additionally, the term "AD disease" was used redundantly in several paragraphs.A correction has been made throughout the article, [Paragraphs 11,12,14,20,21,22,26,and 35]. These sentences previously stated: "AD disease"The corrected sentences now state: "AD"The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

    Keywords: Alzheimer's disease, Plasma Exchange, albumin replacement, Cognitive Function, amyloid-beta, Neurodegenerative disorders

    Received: 11 Oct 2024; Accepted: 16 Oct 2024.

    Copyright: © 2024 Cantero-Fortiz and Boada Rovira. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yahveth Cantero-Fortiz, Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.